Cargando…
Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075874/ https://www.ncbi.nlm.nih.gov/pubmed/31641230 http://dx.doi.org/10.1038/s41379-019-0379-5 |
_version_ | 1783684602492092416 |
---|---|
author | Lawson, Nicola L. Dix, Carly I. Scorer, Paul W. Stubbs, Christopher J. Wong, Edmond Hutchinson, Liam McCall, Eileen J. Schimpl, Marianne DeVries, Emma Walker, Jill Williams, Gareth H. Hunt, James Barker, Craig |
author_facet | Lawson, Nicola L. Dix, Carly I. Scorer, Paul W. Stubbs, Christopher J. Wong, Edmond Hutchinson, Liam McCall, Eileen J. Schimpl, Marianne DeVries, Emma Walker, Jill Williams, Gareth H. Hunt, James Barker, Craig |
author_sort | Lawson, Nicola L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8075874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-80758742021-05-06 Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies Lawson, Nicola L. Dix, Carly I. Scorer, Paul W. Stubbs, Christopher J. Wong, Edmond Hutchinson, Liam McCall, Eileen J. Schimpl, Marianne DeVries, Emma Walker, Jill Williams, Gareth H. Hunt, James Barker, Craig Mod Pathol Correction Nature Publishing Group US 2019-10-22 2020 /pmc/articles/PMC8075874/ /pubmed/31641230 http://dx.doi.org/10.1038/s41379-019-0379-5 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Lawson, Nicola L. Dix, Carly I. Scorer, Paul W. Stubbs, Christopher J. Wong, Edmond Hutchinson, Liam McCall, Eileen J. Schimpl, Marianne DeVries, Emma Walker, Jill Williams, Gareth H. Hunt, James Barker, Craig Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies |
title | Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies |
title_full | Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies |
title_fullStr | Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies |
title_full_unstemmed | Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies |
title_short | Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies |
title_sort | correction: mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075874/ https://www.ncbi.nlm.nih.gov/pubmed/31641230 http://dx.doi.org/10.1038/s41379-019-0379-5 |
work_keys_str_mv | AT lawsonnicolal correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT dixcarlyi correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT scorerpaulw correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT stubbschristopherj correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT wongedmond correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT hutchinsonliam correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT mccalleileenj correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT schimplmarianne correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT devriesemma correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT walkerjill correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT williamsgarethh correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT huntjames correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies AT barkercraig correctionmappingthebindingsitesofantibodiesutilizedinprogrammedcelldeathligand1predictiveimmunohistochemicalassaysforusewithimmunooncologytherapies |